2026年9月25日星期五
M
Hoàn Vũ Thông Giám
Tin nhanh toàn cầu
Talent shortage emerges as tech's biggest bottleneck in AI expansion boom— 日经 Nikkei AsiaJapan's JFE Engineering, startups bet on Philippine renewable energy— 日经 Nikkei AsiaTaiwan's ruling DPP rethinks nuclear power opposition in AI era— 日经 Nikkei AsiaTokyo commercial land prices jump to 33-year high as remote work ebbs— 日经 Nikkei AsiaJapan Air Self-Defense Force confirms Global Hawk drone crash— 日经 Nikkei AsiaJapan trading house lobby chief urges stronger yen despite sector windfall— 日经 Nikkei AsiaUK eyes role in Vietnam infrastructure boom with $2.5bn metro financing— 日经 Nikkei AsiaAustralia's rising far-right leader raises alarm over China's EV influx— 日经 Nikkei AsiaTalent shortage emerges as tech's biggest bottleneck in AI expansion boom— 日经 Nikkei AsiaJapan's JFE Engineering, startups bet on Philippine renewable energy— 日经 Nikkei AsiaTaiwan's ruling DPP rethinks nuclear power opposition in AI era— 日经 Nikkei AsiaTokyo commercial land prices jump to 33-year high as remote work ebbs— 日经 Nikkei AsiaJapan Air Self-Defense Force confirms Global Hawk drone crash— 日经 Nikkei AsiaJapan trading house lobby chief urges stronger yen despite sector windfall— 日经 Nikkei AsiaUK eyes role in Vietnam infrastructure boom with $2.5bn metro financing— 日经 Nikkei AsiaAustralia's rising far-right leader raises alarm over China's EV influx— 日经 Nikkei Asia

Daily administration of Limosilactobacillus mucosae DPC 6426 had negligible effects on blood lipids in mildly hypercholesterolaemic adults

Nguồn Nature 医学研究8 ngày trước
Tóm tắt nội dung

Daily administration of Limosilactobacillus mucosae DPC 6426 had negligible effects on blood lipids in mildly hypercholesterolaemic adults

Trang này chỉ cung cấp tiêu đề và chỉ mục tóm tắt, toàn bộ nội dung và bản quyền đều thuộc về bên phát hành gốc, vui lòng nhấp vào liên kết gốc để đọc.

Đi tới bài gốc
Kênh trực thuộc
Sức khỏe
Khu vực trực thuộc
Góc nhìn toàn cầu
Ngôn ngữ gốc
English
Số mục
health-027a2e64

Comments 0 comments

No comments yet. Be the first.

Daily administration of Limosilactobacillus mucosae DPC 6426 had negligible effects on blood lipids in mildly hypercholesterolaemic adults · Hoàn Vũ Thông Giám